There was no significant association between HPV, metabolic syndrome, and death in men.
The new efforts hinge on broader HPV vaccine access, along with better screening and treatment.
Safety concerns were more prevalent in higher income parents, while knowledge gaps and lack of provider recommendation were more common in their lower income peers.
Girls (43%) were more likely than boys (35%) to have received one or more HPV vaccine doses.
The association was stronger in obese women than in those of a healthy weight.
No invasive cervical cancer cases were seen in women vaccinated against HPV at age 12 or 13 in Scotland, regardless of the number of doses.
The authors recommended following the American Academy of Pediatrics recommendation to begin routine HPV vaccination at age 9.
The outcomes were notable because the study took place during the COVID-19 pandemic, when many routine immunizations were missed.
Four years after vaccination, by age 18, towns that had girls-only or sex-neutral vaccination saw a marked reduction in cancer-causing HPV strains.
Persistent human papillomavirus infections cause most precancerous cervical lesions and cancers.